IIFL Capital starts coverage on India's Cohance with 'buy'
** IIFL Capital initiates coverage on contract research and drug manufacturing firm Cohance Lifesciences COHA.NS with "buy" and PT of 1,140 rupees
** Brokerage says COHA's acquisitions of drugmakers NJ Bio and Sapala strengthen its position in the fast-growing market of antibody drug conjugates (ADC), also known as "guided missile drugs" as they directly target cancer cells, minimizing damage to healthy cells
** Jefferies' PT highest among six analysts tracking COHA - data compiled by LSEG
** Revenue contribution from COHA'S niche tech, which includes these new molecules, is expected to double from 17% in FY25 to over 35% by FY30 - Jefferies
** Avg rating of analysts on COHA at "strong buy"; median PT is 1,235 rupees - data compiled by LSEG
** YTD, COHA stock down 23.4%
Related Articles
Hims & Hers Health Inc (HIMS): The Opportunity is still Strong and Potent
TradingKey - Despite the whole controversy with NVO, we believe HIMS is able to achieve 6 million subscribers and $6 billion of revenue by 2030, due to the large opportunity of growth for the telehealth industry, early investments in logistics capabilities and ability to upsell their patients.
Who Smokes Whom? Altria and Philip Morris International for Tobacco Supremacy
TradingKey - As a U.S. tobacco giant, Altria dominates the cigarette market through subsidiaries like Philip Morris USA but faces severe challenges from declining sales and competition from illicit e-cigarettes..jpg)
Bitcoin Tumbles Nearly 5% in August — Can September Turn the Tide?
Ancient whale wallets dumped Bitcoin throughout August, sending its price on a roller-coaster ride. With September’s Federal Reserve meeting on the horizon, traders are asking: can Fed action spark a BTC rebound?
Eurozone Q2 GDP Commentary: Will the Euro's Upward Momentum Persist?
TradingKey - On 14 August 2025, Eurostat published Q2 GDP figures, revealing a drop in the Eurozone's quarter-on-quarter growth from 0.6% in the first quarter to 0.1%. Consequently, annual growth eased from 1.5% to 1.4%. The slowdown primarily stems from the diminishing boost from European...
Why a 50-Basis-Point Rate Cut in September Should Worry Investors? Risks and Fed Independence Loom Large
TradingKey - After the release of the July nonfarm payrolls and CPI reports, markets have all but locked in expectations for the Federal Reserve to restart rate cuts in September, but the magnitude of the cut remains uncertain. U.S. Treasury Secretary Scott Bessent has called for a 50-basis-point
